Osiris Therapeutics Inc. in Columbia has become the world’s first company to receive market approval for a manufactured stem cell product.
Health Canada, the country’s department responsible for overseeing pharmaceuticals, approved for commercial sale Osiris’ Prochymal, which uses stem cells from healthy donors to treat a fatal children’s disease.
“While today marks the first approval of a stem cell drug, now that the door has been opened, it will surely not be the last,” Osiris CEO C. Randal Mills said.
{iframe}http://www.bizjournals.com/baltimore/news/2012/05/18/osiris-becomes-first-company-to-market.html?ana=e_du_pub&s=article_du&ed=2012-05-18{/iframe}